Impact of Gum Acacia on Chronic Kidney Disease Patients
NCT ID: NCT05599399
Last Updated: 2023-06-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2022-07-18
2023-04-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Role of Activated Charcoal in Decreasing Blood Urea, Creatinine and Phosphorous
NCT04311645
Effect of Inulin on Gut Microbiota and Gut Barrier in Chronic Kidney Disease
NCT05071131
Effects of Resistant Starch Diet on the Gut Microbiome in Chronic Kidney Disease
NCT03356990
The Effect of Probiotics vs Activated Charcoal in the Management of CKD Patients Suffering From Uremic Pruritus.
NCT06579066
Efficacy of Plant-protein Diets in Patients With Chronic Kidney Disease
NCT05350098
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
2. All participants should agree to take part in this clinical study and will provide informed consent.
3. Eighty chronic kidney disease patients,will be recruited from the Kidney and Urology Center (KUC) and Alexandria main university hospital (AMUH).
The 80 participants will be randomly assigned into 2 arms.
Control arm (n=40): will be treated with standard treatment without any herbal intervention.
Intervention arm (n=40): will be treated with standard treatment in addition to gum acacia sachets. Each sachet contains 25 g of gum acacia powder to be taken on daily-basis for 3 months.
4. All patients will be submitted to :
* Full patient history and clinical examination.
* Blood withdrawal in order to conduct lab work.
5. Patients demographic data will be recorded with respect to age, weight and other co-morbidities.
6. Statistical tests appropriate to the study design will be conducted to evaluate the significance of the results.
7. Results, conclusion, discussion and recommendations will be given.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients receiving gum acacia
Group one will receive gum acacia extract as an add-on therapy on daily basis
Gum acacia
25 grams of gum acacia powder is administered on daily-basis
Patients receiving no intervention
Group two will not receive add-on therapy; they will receive standard care only.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Gum acacia
25 grams of gum acacia powder is administered on daily-basis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age: above 18 years
Exclusion Criteria
* Pregnancy \& lactation
* Patients recently treated with antibiotic regimen (2 - 4 weeks)
* Malignancy
* Inflammatory bowel disease
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alexandria University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Merna M. AbouKhatwa, BSc
Role: PRINCIPAL_INVESTIGATOR
Faculty of Pharmacy, Alexandria University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kidney and Urology Center (KUC)
Alexandria, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0107213
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.